secwatch.observer — SEC 8-K summary
======================================

Issuer:     Autolus Therapeutics plc (AUTL)
CIK:        0001730463
Form:       8-K/A
Filed at:   2024-03-15T23:59:59+00:00
Accession:  0001730463-24-000029
Event type: earnings
Sentiment:  neutral
Materiality: 0.10
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Autolus files 8-K/A to furnish Q4 2023 earnings call transcript; no new financial details
--------------------------------------------------------------------------------

- Amendment filed solely to furnish transcript of March 14, 2024 FY2023 earnings call.
- The transcript does not contain specific financial data (revenue, EPS, etc.).
- Original 8-K with press release remains the source for actual financial results.
- No substantive changes were made to the previously filed financial information.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1730463/000173046324000029/0001730463-24-000029-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1730463/000173046324000029/autl-20240314.htm
  HTML page:      https://secwatch.observer/filing/0001730463-24-000029

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer